Florida Woman's Cancer Treatment Delayed by Insurance Denials

Aggressive Cancer Diagnosis and Initial Treatment Plan

• 💡 Mary Barnes was diagnosed with triple negative breast cancer, an aggressive form, in February.
• 🎯 Despite the diagnosis, she has been unable to undergo chemotherapy and radiation for months due to insurance denials.
• 🧠 Her doctor recommended a treatment plan including chemotherapy drugs and the immunotherapy drug Keytruda.

Insurance Denials and Appeals

• ⚠️ United Healthcare initially denied coverage, stating the prescribed regimen did not meet national cancer guidelines.
• 📉 A subsequent appeal was also denied, with the insurer citing a lack of evidence for improved outcomes with the specific treatment.
• 💔 The denials have caused significant anxiety and fear for Mary, especially given the aggressive nature of her cancer.

Discrepancy with Standard Guidelines

• 🔬 The National Comprehensive Cancer Network considers Mary's doctor-recommended chemotherapy to be standard treatment for her condition.
• 📈 While Keytruda may not meet current guidelines for her specific case, clinical trials have shown promising results in similar patients.

Social Media Intervention and Coverage Approval

• 📣 Dr. Alicia Billington, a breast reconstruction surgeon, publicly called out United Healthcare on social media regarding Mary's case.
• ✅ Following media involvement and public pressure, United Healthcare approved Mary's chemotherapy treatment, deeming it medically necessary.
• 🚫 However, the insurer still denied coverage for the immunotherapy drug, Keytruda, citing guideline non-compliance.

Ongoing Struggle and Concerns

• ⏳ Mary, who previously beat ovarian cancer, is concerned that the delay in treatment may have allowed her cancer to spread.
• ❓ United Healthcare has not provided a clear explanation for the initial denial of chemotherapy.
• ⚖️ The insurance company's power significantly impacts Mary's cancer journey, highlighting a complex system of approvals and denials.